Status:
UNKNOWN
Immunochromatography Versus Microscopy for Diagnosis of Entamoeba Histolytica/Dispar Infection.
Lead Sponsor:
Sohag University
Conditions:
Dysentery Amebic
Eligibility:
All Genders
Brief Summary
Amoebiasis, an infection by the protozoan parasite Entamoeba histolytica is globally considered as the third leading parasitic cause of human mortality besides malaria and schistosomiasis. It is estim...
Eligibility Criteria
Inclusion
- Patients complaining of dysentery or diarrhea with any age \& sex groups.
Exclusion
- Patients taking amoebicidal drugs.
Key Trial Info
Start Date :
March 20 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04759937
Start Date
March 20 2021
End Date
December 1 2021
Last Update
October 12 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of medicine-Sohag University
Sohag, Egypt, 093